Citius Pharmaceuticals
CTXR
CTXR
28 hedge funds and large institutions have $947K invested in Citius Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
61% less capital invested
Capital invested by funds: $2.43M → $947K (-$1.48M)
Holders
28
Holding in Top 10
–
Calls
$28K
Puts
$15K
Top Buyers
| 1 | +$59.1K | |
| 2 | +$21.7K | |
| 3 | +$19K | |
| 4 |
Squarepoint
New York
|
+$16.9K |
| 5 |
CCC
Chelsea Counsel Company
Los Angeles,
California
|
+$6.89K |
Top Sellers
| 1 | -$129K | |
| 2 | -$51.2K | |
| 3 | -$49.7K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.67K |
